Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4698-11-7
2. 10-methoxy-5h-dibenzo[b,f]azepine
3. 10-methoxy Iminostilbene
4. 10-methoxy-5h-dibenz[b,f]azepine
5. 5-methoxy-11h-benzo[b][1]benzazepine
6. 10-methoxy-5h-dibenz(b,f)azepine
7. 5h-dibenz[b,f]azepine, 10-methoxy-
8. Oxcarbazepine Ep Impurity H;
9. C935in7u43
10. Mfcd00101079
11. 10-methoxy-5h-dibenzo(b,f)azepine
12. 5h-dibenz(b,f)azepine, 10-methoxy-
13. Einecs 225-172-6
14. Oxcarbazepine Ep Impurity H
15. Unii-c935in7u43
16. 10-methoxydibenzazepine
17. 10-methoxy-dibenz[b,f]azepine
18. Schembl1572195
19. Chembl3580711
20. 10-methoxy-2,2'-iminostilbene
21. Dtxsid20196999
22. Zinc2575314
23. 10-methoxy-5h -dibenz[b,f]azepine
24. Akos015902176
25. Ac-7755
26. Cs-w013089
27. (e)-10-methoxy-5h-dibenzo[b,f]azepine
28. As-13941
29. Sy027357
30. Am20040528
31. Ft-0607193
32. M1895
33. Oxcarbazepine Impurity H [ep Impurity]
34. Ec 225-172-6
35. 10-methoxy-5h-dibenzo[b,f]azepine, Aldrichcpr
36. 698m117
37. A912798
38. Q-100007
39. Q27275341
40. 10-methoxy Iminostilbene; 10-methoxy-5h-dibenzo[b,f]azepine
41. 10-methoxyiminostilbene (10-methoxy-5h-dibenzo[b,f]azepine)
| Molecular Weight | 223.27 g/mol |
|---|---|
| Molecular Formula | C15H13NO |
| XLogP3 | 3.6 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 1 |
| Exact Mass | 223.099714038 g/mol |
| Monoisotopic Mass | 223.099714038 g/mol |
| Topological Polar Surface Area | 21.3 Ų |
| Heavy Atom Count | 17 |
| Formal Charge | 0 |
| Complexity | 299 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
Click Us!
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39014
Submission : 2023-11-20
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38259
Submission : 2023-08-11
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26953
Submission : 2013-03-07
Status : Inactive
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
A 10- Methoxy Iminostilbene manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 10- Methoxy Iminostilbene, including repackagers and relabelers. The FDA regulates 10- Methoxy Iminostilbene manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 10- Methoxy Iminostilbene API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 10- Methoxy Iminostilbene supplier is an individual or a company that provides 10- Methoxy Iminostilbene active pharmaceutical ingredient (API) or 10- Methoxy Iminostilbene finished formulations upon request. The 10- Methoxy Iminostilbene suppliers may include 10- Methoxy Iminostilbene API manufacturers, exporters, distributors and traders.
click here to find a list of 10- Methoxy Iminostilbene suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 10- Methoxy Iminostilbene DMF (Drug Master File) is a document detailing the whole manufacturing process of 10- Methoxy Iminostilbene active pharmaceutical ingredient (API) in detail. Different forms of 10- Methoxy Iminostilbene DMFs exist exist since differing nations have different regulations, such as 10- Methoxy Iminostilbene USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 10- Methoxy Iminostilbene DMF submitted to regulatory agencies in the US is known as a USDMF. 10- Methoxy Iminostilbene USDMF includes data on 10- Methoxy Iminostilbene's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 10- Methoxy Iminostilbene USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 10- Methoxy Iminostilbene suppliers with USDMF on PharmaCompass.
10- Methoxy Iminostilbene Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 10- Methoxy Iminostilbene GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 10- Methoxy Iminostilbene GMP manufacturer or 10- Methoxy Iminostilbene GMP API supplier for your needs.
A 10- Methoxy Iminostilbene CoA (Certificate of Analysis) is a formal document that attests to 10- Methoxy Iminostilbene's compliance with 10- Methoxy Iminostilbene specifications and serves as a tool for batch-level quality control.
10- Methoxy Iminostilbene CoA mostly includes findings from lab analyses of a specific batch. For each 10- Methoxy Iminostilbene CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
10- Methoxy Iminostilbene may be tested according to a variety of international standards, such as European Pharmacopoeia (10- Methoxy Iminostilbene EP), 10- Methoxy Iminostilbene JP (Japanese Pharmacopeia) and the US Pharmacopoeia (10- Methoxy Iminostilbene USP).
LOOKING FOR A SUPPLIER?
